Partnering with manufacturers
Each therapy is as unique as the individual relying on it. That’s why our team takes a consultative, flexible approach with each step.
Tailored, consultative partnership
You’ve developed a one-of-a-kind product that requires precision at every stage. We collaborate with you to understand your long-term strategy and customize our approach based on those needs, along with patients’. It’s a full-service model to help guide advanced therapies.
for rare disease therapies
for distribution and dispensing
for the most unique patients
Emerging therapies require innovative ways to connect data and track longitudinal outcomes. We mobilize the power of the Optum enterprise to develop and execute programs that help inform your commercialization strategy and demonstrate your therapy’s value for patients.
Improving rare disease medication adherence
At least half of people with chronic conditions struggle to follow prescribed treatments, which can negatively affect outcomes. Optum® Frontier Therapies has built an evidence-based tool to identify and address adherence barriers for people on a rare disease therapy.
More about Optum Frontier Therapies
Optum Frontier Therapies was founded to optimize advanced therapeutics, from prescription to treatment and beyond.
Research and consultative services
With services for every partner involved in advanced therapeutics, we help create access, enable collaboration and simplify processes.
We’ve built two centers of distinction, each with sophisticated capabilities tailored to the needs of rare disease and gene therapies.
Interested in strategies to help advance innovative therapies? We’re helping guide the way. Submit your contact information to stay up to date.